Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Khan, , Russell,
DOB: 29-AUG-1980 (Age: 45)
Gender: male
ID: 7982-255119-2 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 19-JAN-2025

Problem list

Condition Onset Date Status
Essential hypertension 15-Sep-2002 active

Medication list

Medication Since Form Dosage Reason
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-01-19 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2025-01-19 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-01-19 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Albuterol (as albuterol sulfate) 830 microgram/mL solution for inhalation 2025-01-19 - 2.5 mg (3 mL of 830 microgram/mL solution) via nebulizer every 4 to 6 hours as needed Childhood asthma
120 ACTUAT fluticasone propionate 0.044 MG/ACTUAT Metered Dose Inhaler [Flovent] 2025-01-19 - 44 mcg inhaled twice daily Childhood asthma

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 19-Jan-2025
COVID-19 non-replicating viral vector vaccine 25-Apr-2021
Hepatitis A virus antigen only vaccine product 27-Dec-2020
Clostridium tetani toxoid antigen adsorbed only vaccine product 27-Dec-2020

Procedure History list

Procedure Date Reason
Plain X-ray of clavicle 26-Sep-2018 -
Admission to orthopedic department 26-Sep-2018 Fracture of clavicle

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 15-Sep-2002 Essential hypertension (disorder)
  • Achieve and maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Patient will demonstrate understanding of hypertension and recommended lifestyle changes (diet, exercise, sodium reduction, weight management, alcohol moderation) within 3 months.
Weight management program 15-Jun-1986 -
Asthma self management 02-Feb-1983 Childhood asthma
  • Patient will maintain peak expiratory flow at or above 80% of personal best through adherence to asthma self-management plan.
  • Patient will have no more than 2 uses of rescue inhaler per week.
  • Patient will experience daytime asthma symptoms no more than 2 days per week.

Vital Signs

Vital Signs 2025-03-13 2025-01-19
Body temperature 37.4 Cel -
Body Height - 168.1 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported - 0 {score}
Body Weight - 80.4 kg
Body mass index (BMI) [Ratio] - 28.5 kg/m2
Diastolic Blood Pressure - 56 mm[Hg]
Systolic Blood Pressure - 76 mm[Hg]
Heart rate - 84 /min
Respiratory rate - 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 19-JAN-2025 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 255.1 H 0 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 110.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 181.2 H 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 51.8 40 - 60 mg/dL